| abstract |
Use of at least one polynucleotide fragment comprising at least 18 consecutive nucleotides whose sequence corresponds to all or part of the region of human chromosome 6 between the markers D6S1629 and D6S257, or whose sequence corresponds to all or part of the region of human chromosome 9 between the marker D9S290 and the long arm telomer, use of agents capable of modifying the function attached to one of these regions, use of the expression products of one of these regions and use of agents capable of modifying the function of these expression products, for cosmetic, therapeutic or diagnostic purposes. |